For the Inventor, By the Inventor

Enter assignee name

Heidelberg, Germany

Universitat Heidelberg

USPTO Granted Patents = 34

% Expired Patents = 17.6

CIPO Patents = 1

EPO Patents = 47

Forward Citations = 77

Loading Chart...

Loading Chart...

123 inventors (with patents filed for the assignee):

Hugo Katus (4 out of 17 patents)

Philipp Uhl (3 out of 3 patents)

Stephan Urban (2 out of 13 patents)

4. Walter Mier (2 out of 22 patents)

5. Uwe Haberkorn (2 out of 20 patents)

6. Henrik Johansson (2 out of 2 patents)

7. Peter Schuisky (2 out of 2 patents)

8. Thomas Pausch (2 out of 2 patents)

9. Thilo Hackert (2 out of 2 patents)

10. Walter Nickel (2 out of 2 patents)

11. Gert Fricker (2 out of 2 patents)

12. Nikolas Dimitriadis (2 out of 2 patents)

13. Nikolaos Deliolanis (2 out of 3 patents)

14. Max Sauter (2 out of 2 patents)

15. Christoph Cremer (2 out of 14 patents)

Core Competencies:

Drug Delivery Systems

Cancer Therapies

Imaging Techniques

Bioactive Compounds

Glioma Treatment

Multispectral Imaging

Cell Penetrating Peptides

Electromechanical Waves

Fluorophores

Tissue Conductivity

Tumor Metabolism

Hydrogenation Reactions

34 patents: Sort by Forward Citations

1. 12755831 - Single-cell morphology analysis for disease profiling and drug discovery (2026-10-06),

2. 12715895 - Sulfur extrusion from disulfides by carbenes (2026-08-25),

3. 12544485 - Method to prevent propagation of irregular electromechanical waves in the myocardium by creating lines of increased tissue conductivity (2026-02-10),

4. 12497423 - SITE-SPECIFIC, KINETICALLY INERT CONJUGATION OF LABELS AND/OR CARRIERS TO TARGET MOLECULES SUCH AS HIS-TAGGED PROTEINS VIA METAL COMPLEX REAGENTS (2025-12-16),

5. 12448606 - Assay for FGF2 secretion and signaling (2025-10-21),

6. 12403060 - Apparatus capable of actuating a distal joint and transferring the constraining reactions in an underactuated shoulder exoskeleton (2025-09-02),

7. 12398405 - Bioactive compound delivery assembly (2025-08-26),

8. 12390535 - Method of making oral dosage forms (2025-08-19),

9. 12029789 - Agent for use in the treatment of glioma (2024-07-09),

10. 11841368 - Method and means for the rapid detection of HDV infections (2023-12-12),

11. 11830598 - Test and optimization of medical treatments for the human eye (2023-11-28),

12. 11730405 - Body fluid leakage detection aqueous composition (2023-08-22),

13. 11618773 - NFAT binding polynucleotides (2023-04-04),

14. 11555063 - Norovirus antibodies (2023-01-17),

15. 11554139 - MIC therapy for specific immunosuppression in transplantation (2023-01-17),

Company Overview

Universität Heidelberg is a prestigious research university located in Heidelberg, Germany, renowned for its commitment to academic excellence and innovation. The institution specializes in a wide range of disciplines, including the humanities, social sciences, natural sciences, and medicine, fostering interdisciplinary collaboration. With a strong emphasis on research, it contributes significantly to advancements in various fields, making it a key player in the global academic landscape and a hub for scholarly exchange and development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

34 Patents

#12 in Heidelberg

#1,454 in Germany

#19,651 in the World

Heidelberg, Germany

Universitat Heidelberg

Forward Citations = 77

123 inventors:

Hugo Katus (4 out of 17 patents)

Philipp Uhl (3 out of 3 patents)

Stephan Urban (2 out of 13 patents)

4. Walter Mier (2 out of 22 patents)

5. Uwe Haberkorn (2 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Universitat Heidelberg. Retrieved from https://idiyas.com/company/universitat-heidelberg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…